--- title: "Ind-Swift Ltd (INDSWFTLTD) — Share Price, Financials & Analysis" symbol: "INDSWFTLTD" company: "Ind-Swift Ltd" canonical: "https://tapetide.com/stocks/INDSWFTLTD" isin: "INE788B01028" nse_symbol: "INDSWFTLTD" sector: "Healthcare" industry: "Pharmaceuticals & Biotechnology" generated_at: "2026-09-13T19:08:36.075Z" --- # Ind-Swift Ltd (INDSWFTLTD) Canonical page: https://tapetide.com/stocks/INDSWFTLTD ## Company - **NSE Symbol:** INDSWFTLTD - **ISIN:** INE788B01028 - **Sector:** Healthcare - **Industry:** Pharmaceuticals & Biotechnology - **Macro Sector:** Healthcare - **Stock Type:** EQUITY - **Listed Since:** 2004-10-18 - **Face Value:** ₹2 - **F&O Eligible:** No - **Website:** indswiftltd.com ## About Incorporated in 1986, Ind-Swift Ltd deals in manufacturing and exporting of pharmaceutical products ## Latest Price - **Price:** ₹15.76 - **Change:** 0 (0%) - **Open:** ₹15.16 - **Day High:** ₹17.82 - **Day Low:** ₹15.15 - **Previous Close:** ₹15.76 - **Volume:** 0 - **As Of:** 2025-08-13T10:16:40+00:00 ## Key Insights ### Strengths - Company has delivered good profit growth of 18.2% CAGR over last 5 years ### Weaknesses - Company has low interest coverage ratio. - The company has delivered a poor sales growth of 9.35% over past five years. - Contingent liabilities of Rs.72.4 Cr. - Earnings include an other income of Rs.328 Cr. ## Growth Rates | Metric | 1Y | 3Y | 5Y | | --- | --- | --- | --- | | net income growth | 132% | 33% | 18% | | revenue growth | 3% | 9% | 9% | ## Financial Statements ### Quarterly Results All figures in ₹ crore unless the row name says otherwise. | Item | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | Sales | 95 | 104 | 107 | 106 | 149 | 116 | 103 | 135 | 114 | 136 | 120 | 145 | | Expenses | 90 | 93 | 89 | 98 | 130 | 105 | 98 | 121 | 111 | 122 | 112 | 148 | | Operating Profit | 5 | 11 | 18 | 8 | 18 | 11 | 4 | 15 | 3 | 14 | 8 | -3 | | OPM % | 5 | 11 | 17 | 8 | 12 | 10 | 4.4 | 11 | 2.8 | 11 | 7 | -2 | | Other Income | 2 | 1 | 3 | 67 | 6 | 3 | 3 | 46 | 40 | 5 | 2 | 281 | | Interest | 15 | 15 | 15 | 14 | 15 | 18 | 15 | 14 | 10 | 10 | 10 | 10 | | Depreciation | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 5 | 5 | 6 | 7 | | Profit before tax | -15 | -11 | -1 | 53 | 2 | -11 | -15 | 40 | 28 | 4 | -6 | 261 | | Tax % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6 | 0 | 0 | 0 | 2 | | Net Profit | -15 | -11 | -1 | 53 | 2 | -11 | -15 | 38 | 28 | 4 | -6 | 257 | | EPS in Rs | -2.85 | -1.95 | -0.19 | 9.8 | 0.44 | -1.98 | -2.76 | 6.93 | 5.21 | 0.76 | -1.01 | 47.34 | ### Profit & Loss All figures in ₹ crore unless the row name says otherwise. | Item | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | Sales | 308 | 263 | 270 | 289 | 330 | 356 | 398 | 411 | 502 | 515 | | Expenses | 465 | 328 | 262 | 278 | 306 | 315 | 352 | 369 | 448 | 492 | | Operating Profit | -157 | -65 | 8 | 11 | 23 | 41 | 45 | 42 | 54 | 23 | | OPM % | -51 | -25 | 2.9 | 3.7 | 7 | 12 | 11 | 10 | 11 | 4.5 | | Other Income | 13 | -246 | -20 | 34 | 22 | 14 | 24 | 72 | 53 | 328 | | Interest | 19 | 16 | 7 | 3 | 29 | 52 | 57 | 60 | 63 | 39 | | Depreciation | 36 | 36 | 35 | 34 | 34 | 33 | 32 | 29 | 27 | 24 | | Profit before tax | -200 | -363 | -53 | 8 | -17 | -29 | -20 | 26 | 16 | 288 | | Tax % | 0 | 0 | 1 | 0 | 15 | 1 | 2 | 0 | 14 | 2 | | Net Profit | -200 | -364 | -54 | 8 | -19 | -30 | -20 | 26 | 14 | 283 | | EPS in Rs | -39.75 | -67.21 | -9.99 | 1.51 | -3.53 | -5.5 | -3.69 | 4.8 | 2.63 | 52.3 | | Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ### Balance Sheet All figures in ₹ crore unless the row name says otherwise. | Item | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | Equity Capital | 10 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | | Reserves | -264 | -636 | -690 | -688 | -724 | -706 | -731 | -716 | -702 | -413 | | Borrowings | 1061 | 1062 | 1055 | 1010 | 1017 | 1023 | 1036 | 993 | 1014 | 874 | | Other Liabilities | 254 | 232 | 237 | 265 | 298 | 344 | 316 | 361 | 331 | 257 | | Total Liabilities | 1061 | 669 | 613 | 598 | 602 | 672 | 632 | 649 | 654 | 728 | | Fixed Assets | 374 | 342 | 311 | 291 | 270 | 244 | 236 | 216 | 184 | 243 | | CWIP | 4 | 2 | 0 | 0 | 0 | 13 | 9 | 30 | 51 | 0 | | Investments | 45 | 44 | 44 | 41 | 24 | 70 | 64 | 54 | 1 | 6 | | Other Assets | 638 | 281 | 258 | 267 | 308 | 344 | 323 | 349 | 418 | 480 | | Total Assets | 1061 | 669 | 613 | 598 | 602 | 672 | 632 | 649 | 654 | 728 | ### Cash Flow All figures in ₹ crore unless the row name says otherwise. | Item | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | Cash from Operating Activity | -106 | 7 | 1 | 43 | 35 | 83 | 50 | 73 | 15 | 16 | | Cash from Investing Activity | -4 | -4 | -3 | -14 | -11 | -17 | -18 | -29 | 77 | 3 | | Cash from Financing Activity | 110 | -11 | -4 | -13 | -26 | -54 | -45 | -47 | -42 | -13 | | Net Cash Flow | 0 | -8 | -5 | 16 | -3 | 12 | -13 | -3 | 50 | 6 | | Free Cash Flow | -110 | 2 | -5 | 29 | 22 | 63 | 31 | 42 | -13 | -25 | | CFO/OP | 67 | -10 | 17 | 397 | 148 | 202 | 111 | 174 | 28 | 69 | ### Ratios | Item | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | Debtor Days | 451 | 151 | 113 | 95 | 104 | 111 | 83 | 93 | 111 | 112 | | Inventory Days | 151 | 86 | 108 | 112 | 102 | 123 | 120 | 150 | 83 | 150 | | Days Payable | 290 | 356 | 426 | 454 | 440 | 454 | 353 | 393 | 262 | 143 | | Cash Conversion Cycle | 311 | -119 | -206 | -246 | -234 | -220 | -149 | -150 | -68 | 120 | | Working Capital Days | -32 | -570 | -563 | -558 | -490 | -482 | -451 | -601 | -30 | 35 | | ROCE % | -20 | -14 | -4 | -4 | 2 | 8 | 11 | 8 | 13 | 12 | ## Shareholding Pattern ### annual | Category | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Jun 2025 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | Promoters | 55.55% | 55.55% | 55.55% | 55.55% | 55.55% | 55.58% | 55.58% | 55.58% | 55.58% | 55.58% | | FIIs | 1.29% | 1.29% | 1.29% | 0.89% | 0% | 0% | 0% | 0% | 0% | 0% | | DIIs | 1.85% | 1.85% | 1.78% | 1.76% | 1.77% | 0% | 0% | 0% | 0% | 0% | | Government | 0% | 0% | 0.38% | 0.62% | 0% | 0% | 0% | 0% | 0% | 0% | | Public | 41.3% | 41.3% | 41% | 41.17% | 42.68% | 44.42% | 44.42% | 44.42% | 44.42% | 44.42% | | No. of Shareholders | 14394 | 13031 | 12720 | 12397 | 11934 | 14009 | 14785 | 16438 | 21368 | 21588 | ### Quarterly | Category | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | Promoters | 55.58% | 55.58% | 55.58% | 55.58% | 55.58% | 55.58% | 55.58% | 55.58% | 55.58% | 55.58% | 55.58% | 55.58% | | Public | 44.42% | 44.4% | 44.42% | 44.42% | 44.42% | 44.42% | 44.42% | 44.42% | 44.42% | 44.43% | 44.42% | 44.42% | | No. of Shareholders | 14422 | 14927 | 14785 | 14590 | 13745 | 14219 | 16438 | 17440 | 18028 | 20936 | 21368 | 21588 | ## Technical Indicators Derived from daily closing prices and recomputed each trading session; values move with the market. - **Overall Signal:** Strong Sell - **Buy / Neutral / Sell:** 1 / 6 / 12 ### Moving Averages — summary: **Strong Sell** | Indicator | Value | Signal | | --- | --- | --- | | SMA (10) | 8.13 | Sell | | EMA (10) | 8.15 | Sell | | SMA (20) | 8.81 | Sell | | EMA (20) | 8.62 | Sell | | SMA (50) | 9.31 | Sell | | EMA (50) | 9.34 | Sell | | SMA (100) | 10.29 | Sell | | EMA (100) | 10.47 | Sell | | SMA (200) | 13.16 | Sell | | EMA (200) | 12.73 | Sell | ### Oscillators — summary: **Sell** | Indicator | Value | Signal | | --- | --- | --- | | RSI (14) | 33.33 | Neutral | | MACD (12,26,9) | -0.54 | Sell | | Stochastic (14,3,3) | 18.46 | Buy | | ADX (14) | 19.64 | Neutral | | Williams %R (14) | -75.93 | Neutral | | ATR (14) | 0.75 | High Volatility | | ROC (12) | -18.17 | Sell | | Stoch RSI (14) | 31.99 | Neutral | | UO (7,14,28) | 33.47 | Neutral | ## Filings & Documents ### Other Documents | Date | Document | | --- | --- | | 31 Jul 2025 - NCLT sanctions Ind-Swift Limited's amalgamation into Ind-Swift Laboratories effective Aug 8, 2025. | [Announcement under Regulation 30 (LODR)-Scheme of Arrangement 31 Jul 2025 - NCLT sanctions Ind-Swift Limited's amalgamation into Ind-Swift Laboratories effective Aug 8, 2025.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/9eba2134-41d9-44cc-b7f1-d6cf552298f7.pdf) | | 31 Jul 2025 - NCLT sanctions Ind-Swift Limited amalgamation into Ind-Swift Laboratories effective Aug 8, 2025. | [Announcement Of Record Date Under Regulation 42 Of SEBI (LODR) Regulation, 2015 31 Jul 2025 - NCLT sanctions Ind-Swift Limited amalgamation into Ind-Swift Laboratories effective Aug 8, 2025.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c3e789b5-0232-4c04-849c-8b1fe3b70dad.pdf) | | 29 Jul 2025 - NCLT approves amalgamation scheme of Ind-Swift Limited with Ind-Swift Laboratories. | [Announcement under Regulation 30 (LODR)-Scheme of Arrangement 29 Jul 2025 - NCLT approves amalgamation scheme of Ind-Swift Limited with Ind-Swift Laboratories.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/cc3331c3-1669-4002-8311-06d04e058651.pdf) | | 22 Jul 2025 - Company Secretary Puneet Khurana resigns effective July 22, 2025, to pursue other opportunities. | [Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer 22 Jul 2025 - Company Secretary Puneet Khurana resigns effective July 22, 2025, to pursue other opportunities.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/807aa9dd-4951-4a1f-9988-81a608f1b42c.pdf) | | 17 Jul 2025 - NCLT approves amalgamation scheme of Ind-Swift Limited with Ind-Swift Laboratories, effective post filing. | [Announcement under Regulation 30 (LODR)-Scheme of Arrangement 17 Jul 2025 - NCLT approves amalgamation scheme of Ind-Swift Limited with Ind-Swift Laboratories, effective post filing.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c6285e88-950b-4ee1-aae4-f8994a78dfaf.pdf) | ### Annual Reports | Date | Document | | --- | --- | | from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/2c7bf10b-d74f-4ad0-b894-e727f6a962ce.pdf) | | from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a30bdb3a-415d-4cd0-b1a8-80908ac9d587.pdf) | | from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/524652/74805524652.pdf) | | from bse | [Annual Report 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/524652/71797524652.pdf) | | from bse | [Annual Report 2020 from bse](https://www.bseindia.com/bseplus/AnnualReport/524652/66877524652.pdf) | | from bse | [Annual Report 2019 from bse](https://www.bseindia.com/bseplus/AnnualReport/524652/5246520319.pdf) | | from bse | [Annual Report 2018 from bse](https://www.bseindia.com/bseplus/AnnualReport/524652/5246520318.pdf) | | from bse | [Annual Report 2017 from bse](https://www.bseindia.com/bseplus/AnnualReport/524652/5246520317.pdf) | | from bse | [Annual Report 2016 from bse](https://www.bseindia.com/bseplus/AnnualReport/524652/5246520316.pdf) | | from bse | [Annual Report 2015 from bse](https://www.bseindia.com/bseplus/AnnualReport/524652/5246520315.pdf) | --- Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T19:08:36.075Z.